$3.45
+0.11 (+3.29%)
Open$3.45
Previous Close$3.34
Day High$3.50
Day Low$3.37
52W High$6.10
52W Low$2.82
Volume—
Avg Volume5.1K
Market Cap33.57M
P/E Ratio—
EPS$-3.27
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,131.3% upside
Current
$3.45
$3.45
Target
$42.48
$42.48
$23.35
$42.48 avg
$52.53
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.05M | 1.15M | 4.21M |
| Net Income | -34,675,813 | -17,461,104 | -76,163 |
| Profit Margin | -1,690.3% | -1,605.8% | -1.8% |
| EBITDA | -32,711,268 | -17,386,954 | -73,642 |
| Free Cash Flow | — | — | -41,548 |
| Rev Growth | +78.7% | +78.7% | +17.4% |
| Debt/Equity | 250.28 | 250.28 | 0.83 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |